| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |